Targeting microbiota-host interactions with resveratrol on cancer: Effects and potential mechanisms of action

References

• Ahn, J., R. Sinha, Z. Pei, C. Dominianni, J. Wu, J. Shi, J. J. Goedert, R. B. Hayes, and L. Yang. 2013. Human gut microbiome and risk for colorectal cancer. Journal of the National Cancer Institute 105 (24):1907–11. doi: 10.1093/jnci/djt300.
   PubMedGoogle Scholar
• Aires, V., E. Limagne, A. K. Cotte, N. Latruffe, F. Ghiringhelli, and D. Delmas. 2013. Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death. Molecular Nutrition & Food Research 57 (7):1170–81. doi: 10.1002/mnfr.201200766.
   PubMed Web of Science ®Google Scholar
• Alghetaa, H., A. Mohammed, J. Zhou, N. Singh, M. Nagarkatti, and P. Nagarkatti. 2021. Resveratrol-mediated attenuation of superantigen-driven acute respiratory distress syndrome is mediated by microbiota in the lungs and gut. Pharmacological Research 167:105548.
   PubMed Web of Science ®Google Scholar
• Alrafas, H. R., P. B. Busbee, K. N. Chitrala, M. Nagarkatti, and P. Nagarkatti. 2020. Alterations in the gut microbiome and suppression of histone deacetylases by resveratrol are associated with attenuation of colonic inflammation and protection against colorectal cancer. Journal of Clinical Medicine 9 (6):1796. doi: 10.3390/jcm9061796.
   PubMed Web of Science ®Google Scholar
• Alrafas, H. R., P. B. Busbee, M. Nagarkatti, and P. S. Nagarkatti. 2019. Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells. Journal of Leukocyte Biology 106 (2):467–80.
   PubMed Web of Science ®Google Scholar
• Álvarez‐Cilleros, D., M. Á. Martín, and S. Ramos. 2018. (‐)‐Epicatechin and the colonic 2, 3‐dihydroxybenzoic acid metabolite regulate glucose uptake, glucose production, and improve insulin signaling in renal NRK‐52E cells. Molecular Nutrition & Food Research 62 (4):1700470. doi: 10.1002/mnfr.201700470.
   Web of Science ®Google Scholar
• Andres-Lacueva, C., M. T. Macarulla, M. Rotches-Ribalta, M. Boto-Ordóñez, M. Urpi-Sarda, V. M. Rodríguez, and M. P. Portillo. 2012. Distribution of resveratrol metabolites in liver, adipose tissue, and skeletal muscle in rats fed different doses of this polyphenol. Journal of Agricultural and Food Chemistry 60 (19):4833–40.
   PubMed Web of Science ®Google Scholar
• Anisimova, N. Y., M. V. Kiselevsky, A. V. Sosnov, S. V. Sadovnikov, I. N. Stankov, and A. A. Gakh. 2011. Trans-, cis-, and dihydro-resveratrol: a comparative study. Chemistry Central Journal 5 (1):1–6. doi: 10.1186/1752-153X-5-88.
   PubMedGoogle Scholar
• Azorín-Ortuño, M., M. J. Yáñez-Gascón, A. González-Sarrías, M. Larrosa, F. Vallejo, F. J. Pallarés, R. Lucas, J. C. Morales, F. A. Tomás-Barberán, M.-T. García-Conesa, et al. 2012. Effects of long-term consumption of low doses of resveratrol on diet-induced mild hypercholesterolemia in pigs: a transcriptomic approach to disease prevention. The Journal of Nutritional Biochemistry 23 (7):829–37.
   PubMed Web of Science ®Google Scholar
• Böhmdorfer, M., A. Szakmary, R. H. Schiestl, J. Vaquero, J. Riha, S. Brenner, T. Thalhammer, T. Szekeres, and W. Jäger. 2017. Involvement of UDP-glucuronosyltransferases and sulfotransferases in the excretion and tissue distribution of resveratrol in mice. Nutrients 9 (12):1347. doi: 10.3390/nu9121347.
   PubMed Web of Science ®Google Scholar
• Bae, S., C. M. Ulrich, M. L. Neuhouser, O. Malysheva, L. B. Bailey, L. Xiao, E. C. Brown, K. L. Cushing-Haugen, Y. Zheng, T.-Y D. Cheng, et al. 2014. Plasma choline metabolites and colorectal cancer risk in the Women’s Health Initiative Observational Study. Cancer Research 74 (24):7442–52.
   PubMed Web of Science ®Google Scholar
• Banik, K., A. M. Ranaware, C. Harsha, T. Nitesh, S. Girisa, V. Deshpande, L. Fan, S. P. Nalawade, G. Sethi, and A. B. Kunnumakkara. 2020. Piceatannol: a natural stilbene for the prevention and treatment of cancer. Pharmacological Research 153:104635.
   PubMed Web of Science ®Google Scholar
• Basholli-Salihu, M., R. Schuster, D. Mulla, W. Praznik, H. Viernstein, and M. Mueller. 2016. Bioconversion of piceid to resveratrol by selected probiotic cell extracts. Bioprocess and Biosystems Engineering 39 (12):1879–85. doi: 10.1007/s00449-016-1662-1.
   PubMed Web of Science ®Google Scholar
• Bauld, L., R. J. Beeken, J. Brand, W. Demark-Wahnefried, H. Drakesmith, T. Dwyer, C. Frezza, E. L. Giovannucci, M. J. Gunter, S. D. Hursting, et al. 2019. Current opportunities to catalyze research in nutrition and cancer prevention - an interdisciplinary perspective. BMC Medicine 17.
   Web of Science ®Google Scholar
• Behary, J., N. Amorim, X.-T. Jiang, A. Raposo, L. Gong, E. McGovern, R. Ibrahim, F. Chu, C. Stephens, H. Jebeili, et al. 2021. Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma. Nature Communications 12 (1):1–14. doi: 10.1038/s41467-020-20422-7.
   PubMed Web of Science ®Google Scholar
• Bertelli, A., L. Giovannini, R. Stradi, A. Bertelli, and J. Tillement. 1996. Plasma, urine and tissue levels of trans-and cis-resveratrol (3, 4’, 5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reactions 18 (2-3):67–71.
   PubMedGoogle Scholar
• Bode, L. M., D. Bunzel, M. Huch, G.-S. Cho, D. Ruhland, M. Bunzel, A. Bub, C. M. Franz, and S. E. Kulling. 2013. In vivo and in vitro metabolism of trans-resveratrol by human gut microbiota. The American Journal of Clinical Nutrition 97 (2):295–309.
   PubMed Web of Science ®Google Scholar
• Boocock, D. J., G. E. Faust, K. R. Patel, A. M. Schinas, V. A. Brown, M. P. Ducharme, T. D. Booth, J. A. Crowell, M. Perloff, A. J. Gescher, et al. 2007. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiology, Biomarkers & Prevention 16 (6):1246–52. doi: 10.1158/1055-9965.EPI-07-0022.
   PubMed Web of Science ®Google Scholar
• Byrd, D. A., E. Vogtmann, Z. Wu, Y. Han, Y. Wan, J. ‐N. Clegg‐Lamptey, J. Yarney, B. Wiafe‐Addai, S. Wiafe, B. Awuah, et al. 2021. Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study. International Journal of Cancer 148 (11):2712–23. doi: 10.1002/ijc.33473.
   PubMed Web of Science ®Google Scholar
• Cai, H., E. Scott, A. Kholghi, C. Andreadi, A. Rufini, A. Karmokar, R. G. Britton, E. Horner-Glister, P. Greaves, D. Jawad, et al. 2015. Cancer chemoprevention: evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice. Science Translational Medicine 7 (298):298ra117.
   PubMed Web of Science ®Google Scholar
• Cai, H., E. N. Scott, R. G. Britton, E. Parrott, T. J. Ognibene, M. Malfatti, M. Khan, W. P. Steward, and K. Brown. 2021. Distribution and metabolism of [14C]-resveratrol in human prostate tissue after oral administration of a “dietary-achievable” or “pharmacological” dose: what are the implications for anticancer activity? The American Journal of Clinical Nutrition 113 (5):1115–25. doi: 10.1093/ajcn/nqaa414.
   PubMed Web of Science ®Google Scholar
• Campbell, C. L., R. Yu, F. Li, Q. Zhou, D. Chen, C. Qi, Y. Yin, and J. Sun. 2019. Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 12:97–107. doi: 10.2147/DMSO.S192228.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (7):1761–72. doi: 10.2337/db06-1491.
   PubMed Web of Science ®Google Scholar
• Canistro, D., B. Bonamassa, L. Pozzetti, A. Sapone, S. Abdel-Rahman, G. Biagi, and M. Paolini. 2009. Alteration of xenobiotic metabolizing enzymes by resveratrol in liver and lung of CD1 mice. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 47 (2):454–61.
   PubMed Web of Science ®Google Scholar
• Cao, H., P. Högger, M. A. Prieto, J. Simal‐Gandara, and J. Xiao. 2022. Stability of quercetin in DMEM and cell culture with A549 cells. eFood 3 (3):e13. doi: 10.1002/efd2.13.
   Google Scholar
• Carrasco-Pozo, C., K. N. Tan, and V. M. Avery. 2020. Hemin prevents increased glycolysis in macrophages upon activation: protection by microbiota-derived metabolites of polyphenols. Antioxidants 9 (11):1109. doi: 10.3390/antiox9111109.
   Web of Science ®Google Scholar
• Castellarin, M., R. L. Warren, J. D. Freeman, L. Dreolini, M. Krzywinski, J. Strauss, R. Barnes, P. Watson, E. Allen-Vercoe, R. A. Moore, et al. 2012. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Research 22 (2):299–306.
   PubMed Web of Science ®Google Scholar
• Catalkaya, G., K. Venema, L. Lucini, G. Rocchetti, D. Delmas, M. Daglia, A. D. Filippis, H. Xiao, J. L. Quiles, J. Xiao, et al. 2020. Interaction of dietary polyphenols and gut microbiota: microbial metabolism of polyphenols, influence on the gut microbiota, and implications on host health. Food Frontiers 1 (2):109–33. doi: 10.1002/fft2.25.
   Google Scholar
• Chang, T., J. Chen, and C.-T. Yu. 2007. In vitro inhibition of rat CYP1A1 and CYP1A2 by piceatannol, a hydroxylated metabolite of trans-resveratrol. Drug Metabolism Letters 1 (1):13–6.
   PubMedGoogle Scholar
• Chen, L., S. Yang, E. E. Zumbrun, H. Guan, P. S. Nagarkatti, and M. Nagarkatti. 2015. Resveratrol attenuates lipopolysaccharide‐induced acute kidney injury by suppressing inflammation driven by macrophages. Molecular Nutrition & Food Research 59 (5):853–64. doi: 10.1002/mnfr.201400819.
   PubMed Web of Science ®Google Scholar
• Chen, M-l., L. Yi, X. Jin, Q. Xie, T. Zhang, X. Zhou, H. Chang, Y-j Fu, J-d Zhu, Q-y Zhang, et al. 2013. Absorption of resveratrol by vascular endothelial cells through passive diffusion and an SGLT1-mediated pathway. The Journal of Nutritional Biochemistry 24 (11):1823–9. doi: 10.1016/j.jnutbio.2013.04.003.
   PubMed Web of Science ®Google Scholar
• Chen, M-l., L. Yi, Y. Zhang, X. Zhou, L. Ran, J. Yang, J-d Zhu, Q-y Zhang, and M-t Mi. 2016. Resveratrol attenuates trimethylamine-N-oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio 7 (2):e02210-02215–e02215. doi: 10.1128/mBio.02210-15.
   Web of Science ®Google Scholar
• Chen, M., P. Hou, M. Zhou, Q. Ren, X. Wang, L. Huang, S. Hui, L. Yi, and M. Mi. 2020. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clinical Nutrition (Edinburgh, Scotland) 39 (4):1264–75. doi: 10.1016/j.clnu.2019.05.020.
   PubMed Web of Science ®Google Scholar
• Cheng, G., S. Yang, G. Zhang, Y. Xu, X. Liu, W. Sun, and L. Zhu. 2016. Lipopolysaccharide-induced α-catenin downregulation enhances the motility of human colorectal cancer cells in an NF-κB signaling-dependent manner. OncoTargets and Therapy 9:7563–71. doi: 10.2147/OTT.S123986.
   PubMed Web of Science ®Google Scholar
• Chow, H. S., L. L. Garland, C.-H. Hsu, D. R. Vining, W. M. Chew, J. A. Miller, M. Perloff, J. A. Crowell, and D. S. Alberts. 2010. Resveratrol modulates drug-and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prevention Research 3 (9):1168–75. doi: 10.1158/1940-6207.CAPR-09-0155.
   PubMed Web of Science ®Google Scholar
• Chu, F., Y. Li, X. Meng, Y. Li, T. Li, M. Zhai, H. Zheng, T. Xin, Z. Su, J. Lin, et al. 2021. Gut microbial dysbiosis and changes in fecal metabolic phenotype in precancerous lesions of gastric cancer induced with N-methyl-N′-nitro-N-nitrosoguanidine, sodium salicylate, ranitidine, and irregular diet. Frontiers in Physiology 12:733979. doi: 10.3389/fphys.2021.733979.
   PubMed Web of Science ®Google Scholar
• Cianciosi, D., T. Y. Forbes‐Hernández, F. Giampieri, J. Zhang, J. Ansary, M. Pacetti, J. L. Quiles, J. Simal‐Gandara, and M. Battino. 2020. Effect of in vitro gastrointestinal digestion on the bioaccessibility of phenolic compounds and antioxidant activity of Manuka honey. eFood 1 (1):85–93. doi: 10.2991/efood.k.191011.001.
   Google Scholar
• Clavel, T., C. Desmarchelier, D. Haller, P. Gérard, S. Rohn, P. Lepage, and H. Daniel. 2014. Intestinal microbiota in metabolic diseases: from bacterial community structure and functions to species of pathophysiological relevance. Gut Microbes 5 (4):544–51. doi: 10.4161/gmic.29331.
   PubMed Web of Science ®Google Scholar
• Cui, Q., Y. Pan, W. Zhang, Y. Zhang, S. Ren, D. Wang, Z. Wang, X. Liu, and W. Xiao. 2018. Metabolites of dietary acteoside: profiles, isolation, identification, and hepatoprotective capacities. Journal of Agricultural and Food Chemistry 66 (11):2660–8. doi: 10.1021/acs.jafc.7b04650.
   PubMed Web of Science ®Google Scholar
• Dai, Y., J. X. Lim, S. C. M. Yeo, X. Xiang, K. S. Tan, J. H. Fu, L. Huang, and H. S. Lin. 2020. Biotransformation of piceatannol, a dietary resveratrol derivative: promises to human health. Molecular Nutrition & Food Research 64 (2):1900905. doi: 10.1002/mnfr.201900905.
   Web of Science ®Google Scholar
• Dai, Z., O. O. Coker, G. Nakatsu, W. K. K. Wu, L. Zhao, Z. Chen, F. K. L. Chan, K. Kristiansen, J. J. Y. Sung, S. H. Wong, et al. 2018. Multi-cohort analysis of colorectal cancer metagenome identified altered bacteria across populations and universal bacterial markers. Microbiome 6 (1):1–12. doi: 10.1186/s40168-018-0451-2.
   PubMedGoogle Scholar
• de Aguiar Vallim, T. Q., E. J. Tarling, and P. A. Edwards. 2013. Pleiotropic roles of bile acids in metabolism. Cell Metabolism 17 (5):657–69.
   PubMed Web of Science ®Google Scholar
• Deus, C. M., T. L. Serafim, S. Magalhaes-Novais, A. Vilaca, A. C. Moreira, V. A. Sardao, S. M. Cardoso, and P. J. Oliveira. 2017. Sirtuin 1-dependent resveratrol cytotoxicity and pro-differentiation activity on breast cancer cells. Archives of Toxicology 91 (3):1261–78.
   PubMed Web of Science ®Google Scholar
• Di Modica, M., G. Gargari, V. Regondi, A. Bonizzi, S. Arioli, B. Belmonte, L. De Cecco, E. Fasano, F. Bianchi, A. Bertolotti, et al. 2021. Gut microbiota condition the therapeutic efficacy of trastuzumab in HER2-positive breast cancer. Cancer Research 81 (8):2195–206.
   PubMed Web of Science ®Google Scholar
• Doocey, C. M., K. Finn, C. Murphy, and C. M. Guinane. 2022. The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development. BMC Microbiology 22 (1):53–70.
   PubMed Web of Science ®Google Scholar
• Erridge, C., T. Attina, C. M. Spickett, and D. J. Webb. 2007. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. The American Journal of Clinical Nutrition 86 (5):1286–92. doi: 10.1093/ajcn/86.5.1286.
   PubMed Web of Science ®Google Scholar
• Fukata, M., A. Chen, A. S. Vamadevan, J. Cohen, K. Breglio, S. Krishnareddy, D. Hsu, R. Xu, N. Harpaz, A. J. Dannenberg, et al. 2007. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 133 (6):1869–1869.e1814. doi: 10.1053/j.gastro.2007.09.008.
   PubMed Web of Science ®Google Scholar
• Furimsky, A. M., C. E. Green, L. E. H. Sharp, P. Catz, A. A. Adjei, T. Parman, I. M. Kapetanovic, R. M. Weinshilboum, and L. V. Iyer. 2008. Effect of resveratrol on 17β-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1. Drug Metabolism and Disposition: The Biological Fate of Chemicals 36 (1):129–36.
   PubMed Web of Science ®Google Scholar
• Gagnière, J., J. Raisch, J. Veziant, N. Barnich, R. Bonnet, E. Buc, M.-A. Bringer, D. Pezet, and M. Bonnet. 2016. Gut microbiota imbalance and colorectal cancer. World Journal of Gastroenterology 22 (2):501–18.
   PubMed Web of Science ®Google Scholar
• Gholizadeh, P., H. Eslami, and H. S. Kafil. 2017. Carcinogenesis mechanisms of Fusobacterium nucleatum. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 89:918–25. doi: 10.1016/j.biopha.2017.02.102.
   PubMed Web of Science ®Google Scholar
• Giménez‐Bastida, J. A., M. Á. Ávila‐Gálvez, J. C. Espín, and A. González‐Sarrías. 2019. Conjugated physiological resveratrol metabolites induce senescence in breast cancer cells: role of p53/p21 and p16/Rb pathways, and ABC transporters. Molecular Nutrition & Food Research 63 (22):1900629. doi: 10.1002/mnfr.201900629.
   Web of Science ®Google Scholar
• Goedert, J. J., G. Jones, X. Hua, X. Xu, G. Yu, R. Flores, R. T. Falk, M. H. Gail, J. Shi, J. Ravel, et al. 2015. Investigation of the association between the fecal microbiota and breast cancer in postmenopausal women: a population-based case-control pilot study. JNCI: Journal of the National Cancer Institute 107 (8): 1–5. doi: 10.1093/jnci/djv147.
   Google Scholar
• Golombos, D. M., A. Ayangbesan, P. O’Malley, P. Lewicki, L. Barlow, C. E. Barbieri, C. Chan, C. DuLong, G. Abu-Ali, C. Huttenhower, et al. 2018. The role of gut microbiome in the pathogenesis of prostate cancer: a prospective, pilot study. Urology 111:122–8. doi: 10.1016/j.urology.2017.08.039.
   PubMed Web of Science ®Google Scholar
• Gonthier, M. P., V. Cheynier, J. L. Donovan, C. Manach, C. Morand, I. Mila, C. Lapierre, C. Remesy, and A. Scalbert. 2003. Microbial aromatic acid metabolites formed in the gut account for a major fraction of the polyphenols excreted in urine of rats fed red wine polyphenols. The Journal of Nutrition 133 (2):461–7. doi: 10.1093/jn/133.2.461.
   PubMed Web of Science ®Google Scholar
• Harbi, S. M., R. A. Hussien, I. Hawasawi, I. Alshdoukhi, V. Chopra, A. N. Alanazi, W. Butler, R. Koroma, C. Peters, D. D. Garver, et al. 2020. Red blood cells and lipoproteins: important reservoirs and transporters of polyphenols and their metabolites. Journal of Agricultural and Food Chemistry 68 (26):7005–13.
   PubMed Web of Science ®Google Scholar
• Hebbar, V., G. Shen, R. Hu, B.-R. Kim, C. Chen, P. J. Korytko, J. A. Crowell, B. S. Levine, and A.-N T. Kong. 2005. Toxicogenomics of resveratrol in rat liver. Life Sciences 76 (20):2299–314.
   PubMed Web of Science ®Google Scholar
• Henry, C., X. Vitrac, A. Decendit, R. Ennamany, S. Krisa, and J.-M. Mérillon. 2005. Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. Journal of Agricultural and Food Chemistry 53 (3):798–803.
   PubMed Web of Science ®Google Scholar
• Holme, A. L, and S. Pervaiz. 2007. Resveratrol in cell fate decisions. Journal of Bioenergetics and Biomembranes 39 (1):59–63.
   PubMed Web of Science ®Google Scholar
• Hsu, R. Y., C. H. Chan, J. D. Spicer, M. C. Rousseau, B. Giannias, S. Rousseau, and L. E. Ferri. 2011. LPS-induced TLR4 signaling in human colorectal cancer cells increases β1 integrin-mediated cell adhesion and liver metastasis. Cancer Research 71 (5):1989–98. doi: 10.1158/0008-5472.CAN-10-2833.
   PubMed Web of Science ®Google Scholar
• Hu, W.-H., R. Duan, Y.-T. Xia, Q.-P. Xiong, H.-Y. Wang, G. K.-L. Chan, S.-Y. Liu, T. T.-X. Dong, Q.-W. Qin, and K. W.-K. Tsim. 2019. Binding of resveratrol to vascular endothelial growth factor suppresses angiogenesis by inhibiting the receptor signaling. Journal of Agricultural and Food Chemistry 67 (4):1127–37. doi: 10.1021/acs.jafc.8b05977.
   PubMed Web of Science ®Google Scholar
• Huang, H., Z. Ren, X. Gao, X. Hu, Y. Zhou, J. Jiang, H. Lu, S. Yin, J. Ji, L. Zhou, et al. 2020. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma. Genome Medicine 12 (1):1–14. doi: 10.1186/s13073-020-00796-5.
   Web of Science ®Google Scholar
• Huang, M., Y. Han, L. Li, K. Rakariyatham, X. Wu, Z. Gao, and H. Xiao. 2022. Protective effects of non-extractable phenolics from strawberry against inflammation and colon cancer in vitro. Food Chemistry 374:131759.
   PubMed Web of Science ®Google Scholar
• Huang, Y., Y. Chen, S. Lu, and C. Zhao. 2021. Recent advance of in vitro models in natural phytochemicals absorption and metabolism. eFood 2 (6):307–18. doi: 10.53365/efood.k/146945.
   Google Scholar
• Hui, S., Y. Liu, L. Huang, L. Zheng, M. Zhou, H. Lang, X. Wang, L. Yi, and M. Mi. 2020. Resveratrol enhances brown adipose tissue activity and white adipose tissue browning in part by regulating bile acid metabolism via gut microbiota remodeling. International Journal of Obesity (2005) 44 (8):1678–90. doi: 10.1038/s41366-020-0566-y.
   PubMed Web of Science ®Google Scholar
• Hyrsova, L., A. Vanduchova, J. Dusek, T. Smutny, A. Carazo, V. Maresova, F. Trejtnar, P. Barta, P. Anzenbacher, Z. Dvorak, et al. 2019. Trans-resveratrol, but not other natural stilbenes occurring in food, carries the risk of drug-food interaction via inhibition of cytochrome P450 enzymes or interaction with xenosensor receptors. Toxicology Letters 300:81–91. doi: 10.1016/j.toxlet.2018.10.028.
   PubMed Web of Science ®Google Scholar
• Jang, M. S., E. N. Cai, G. O. Udeani, K. V. Slowing, C. F. Thomas, C. W. W. Beecher, H. H. S. Fong, N. R. Farnsworth, A. D. Kinghorn, R. G. Mehta, et al. 1997. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 (5297):218–20. doi: 10.1126/science.275.5297.218.
   PubMed Web of Science ®Google Scholar
• Jannin, B., M. Menzel, J.-P. Berlot, D. Delmas, A. Lançon, and N. Latruffe. 2004. Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochemical Pharmacology 68 (6):1113–8.
   PubMed Web of Science ®Google Scholar
• Jensen, J. 2017. Enzymatic transformations of resveratrol from red wine. Northridge: California State University.
   Google Scholar
• Jin, L., M. L. Wang, Y. Lv, X. Y. Zeng, C. Chen, H. Ren, H. Luo, and W. D. Pan. 2019. Design and synthesis of flavonoidal ethers and their anti-cancer activity in vitro. Molecules 24 (9):1749. doi: 10.3390/molecules24091749.
   PubMed Web of Science ®Google Scholar
• Kühn, G., K. Pallauf, C. Schulz, M. Birringer, B. Diaz-Rica, S. de Pascual-Teresa, and G. Rimbach. 2018. Resveratrol modulates desaturase expression and fatty acid composition of cultured hepatocytes. Frontiers in Nutrition 5:106.
   PubMed Web of Science ®Google Scholar
• Kaldas, M. I., U. K. Walle, and T. Walle. 2003. Resveratrol transport and metabolism by human intestinal Caco‐2 cells. The Journal of Pharmacy and Pharmacology 55 (3):307–12.
   PubMed Web of Science ®Google Scholar
• Kawakita, D., Y. C. A. Lee, L. H. Gren, S. S. Buys, C. La Vecchia, and M. Hashibe. 2019. Fiber intake and the risk of head and neck cancer in the prostate, lung, colorectal and ovarian (PLCO) cohort. International Journal of Cancer 145 (9):2342–8.
   PubMed Web of Science ®Google Scholar
• Kaźmierczak-Siedlecka, K., A. Daca, M. Fic, T. van de Wetering, M. Folwarski, and W. Makarewicz. 2020. Therapeutic methods of gut microbiota modification in colorectal cancer management–fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes 11 (6):1518–30.
   PubMed Web of Science ®Google Scholar
• Kenealey, J. D., L. Subramanian, P. R. Van Ginkel, S. Darjatmoko, M. J. Lindstrom, V. Somoza, S. K. Ghosh, Z. Song, R. P. Hsung, G. S. Kwon, et al. 2011. Resveratrol metabolites do not elicit early pro-apoptotic mechanisms in neuroblastoma cells. Journal of Agricultural and Food Chemistry 59 (9):4979–86. doi: 10.1021/jf104901g.
   PubMed Web of Science ®Google Scholar
• Khanal, R., L. R. Howard, and R. L. Prior. 2014. Urinary excretion of phenolic acids in rats fed cranberry, blueberry, or black raspberry powder. Journal of Agricultural and Food Chemistry 62 (18):3987–96. doi: 10.1021/jf403883r.
   PubMed Web of Science ®Google Scholar
• Kim, Y. N., S. R. Choe, K. H. Cho, D. Y. Cho, J. Kang, C. G. Park, and H. Y. Lee. 2017. Resveratrol suppresses breast cancer cell invasion by inactivating a RhoA/YAP signaling axis. Experimental and Molecular Medicine 49 (2):e296.
   PubMed Web of Science ®Google Scholar
• Kostic, A. D., E. Chun, L. Robertson, J. N. Glickman, C. A. Gallini, M. Michaud, T. E. Clancy, D. C. Chung, P. Lochhead, G. L. Hold, et al. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe 14 (2):207–15.
   PubMed Web of Science ®Google Scholar
• Kuhnle, G., J. P. Spencer, G. Chowrimootoo, H. Schroeter, E. S. Debnam, S. K. S. Srai, C. Rice-Evans, and U. Hahn. 2000. Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochemical and Biophysical Research Communications 272 (1):212–7.
   PubMed Web of Science ®Google Scholar
• Kumar, S., E. Eroglu, J. A. Stokes, III, K. Scissum-Gunn, S. N. Saldanha, U. P. Singh, U. Manne, S. Ponnazhagan, and M. K. Mishra. 2017. Resveratrol induces mitochondria-mediated, caspase-independent apoptosis in murine prostate cancer cells. Oncotarget 8 (13):20895–908.
   PubMedGoogle Scholar
• Kurogi, K., A. Chepak, M. T. Hanrahan, M.-Y. Liu, Y. Sakakibara, M. Suiko, and M.-C. Liu. 2014. Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 62:40–8.
   PubMed Web of Science ®Google Scholar
• Kwong, T. N. Y., X. Wang, G. Nakatsu, T. C. Chow, T. Tipoe, R. Z. W. Dai, K. K. K. Tsoi, M. C. S. Wong, G. Tse, M. T. V. Chan, et al. 2018. Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer. Gastroenterology 155 (2):383–90.
   PubMed Web of Science ®Google Scholar
• López-Yerena, A., M. Perez, A. Vallverdú-Queralt, and E. Escribano-Ferrer. 2020. Insights into the binding of dietary phenolic compounds to human serum albumin and food-drug interactions. Pharmaceutics 12 (11):1123. doi: 10.3390/pharmaceutics12111123.
   PubMed Web of Science ®Google Scholar
• Lançon, A., N. Hanet, B. Jannin, D. Delmas, J.-M. Heydel, G. Lizard, M.-C. Chagnon, Y. Artur, and N. Latruffe. 2007. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metabolism and Disposition: The Biological Fate of Chemicals 35 (5):699–703.
   PubMed Web of Science ®Google Scholar
• Latruffe, N., M. Menzel, D. Delmas, R. Buchet, and A. Lançon. 2014. Compared binding properties between resveratrol and other polyphenols to plasmatic albumin: consequences for the health protecting effect of dietary plant microcomponents. Molecules (Basel, Switzerland) 19 (11):17066–77. doi: 10.3390/molecules191117066.
   PubMed Web of Science ®Google Scholar
• Li, F., Y. Han, X. Cai, M. Gu, J. Sun, C. Qi, T. Goulette, M. Song, Z. Li, and H. Xiao. 2020. Dietary resveratrol attenuated colitis and modulated gut microbiota in dextran sulfate sodium-treated mice. Food & Function 11 (1):1063–73.
   PubMed Web of Science ®Google Scholar
• Li, Q., Y. Yue, L. Chen, C. Xu, Y. Wang, L. Du, X. Xue, Q. Liu, Y. Wang, and F. Fan. 2018. Resveratrol sensitizes carfilzomib-induced apoptosis via promoting oxidative stress in multiple myeloma cells. Frontiers in Pharmacology 9:334.
   PubMed Web of Science ®Google Scholar
• Li, Y., Y. X. Yang, X. P. Liu, Y. W. Long, and Y. H. Zheng. 2019. PRMT5 promotes human lung cancer cell apoptosis via Akt/Gsk3 beta signaling induced by resveratrol. Cell Transplantation 28 (12):1664–73. doi: 10.1177/0963689719885083.
   PubMed Web of Science ®Google Scholar
• Liang, L., X. Liu, Q. Wang, S. Cheng, S. Zhang, and M. Zhang. 2013a. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3,5,4 ‘-tri-O-acetylresveratrol in rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 20 (6):558–63. doi: 10.1016/j.phymed.2012.12.012.
   PubMed Web of Science ®Google Scholar
• Liang, L., X. Liu, Q. Wang, S. Cheng, S. Zhang, and M. Zhang. 2013b. Pharmacokinetics, tissue distribution and excretion study of resveratrol and its prodrug 3, 5, 4′-tri-O-acetylresveratrol in rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 20 (6):558–63. doi: 10.1016/j.phymed.2012.12.012.
   PubMed Web of Science ®Google Scholar
• Licznerska, B., H. Szaefer, M. Wierzchowski, H. Sobierajska, and W. Baer-Dubowska. 2017. Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation. Molecular and Cellular Biochemistry 425 (1-2):169–79.
   PubMed Web of Science ®Google Scholar
• Lin, X., C. Cheng, J. Zhong, B. Liu, C. Luo, W. Ou, P. Mo, Q. Huang, and S. Liu. 2018. Resveratrol inhibits angiotensin II‑induced proliferation of A7r5 cells and decreases neointimal hyperplasia by inhibiting the CaMKII‑HDAC4 signaling pathway. Molecular Medicine Reports 18 (1):1007–14.
   PubMed Web of Science ®Google Scholar
• Lin, Z. S., C. F. Ku, Y. F. Guan, H. T. Xiao, X. K. Shi, H. Q. Wang, Z. X. Bian, S. W. Tsang, and H. J. Zhang. 2016. Dihydro‐resveratrol ameliorates lung injury in rats with cerulein‐induced acute pancreatitis. Phytotherapy Research: PTR 30 (4):663–70.
   PubMed Web of Science ®Google Scholar
• Lou, B.-S., P.-S. Wu, C.-W. Hou, F-y Cheng, and J.-K. Chen. 2014. Simultaneous quantification of trans-resveratrol and its sulfate and glucuronide metabolites in rat tissues by stable isotope-dilution UPLC–MS/MS analysis. Journal of Pharmaceutical and Biomedical Analysis 94:99–105.
   PubMed Web of Science ®Google Scholar
• Luna-Guevara, M. L., J. J. Luna-Guevara, P. Hernández-Carranza, H. Ruíz-Espinosa, and C. E. Ochoa-Velasco. 2018. Phenolic compounds: a good choice against chronic degenerative diseases. In Studies in natural products chemistry, ed. Atta-ur- Rahman, Vol. 59, 79–108. Elsevier.
   Google Scholar
• Mahyar-Roemer, M., H. Kohler, and K. Roemer. 2002. Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer 2 (1):1–9. doi: 10.1186/1471-2407-2-27.
   PubMedGoogle Scholar
• Manuzak, J. A., T. Hensley-McBain, A. S. Zevin, C. Miller, R. Cubas, B. Agricola, J. Gile, L. Richert-Spuhler, G. Patilea, J. D. Estes, et al. 2016. Enhancement of microbiota in healthy macaques results in beneficial modulation of mucosal and systemic immune function. Journal of Immunology (Baltimore, Md.: 1950) 196 (5):2401–9.
   PubMed Web of Science ®Google Scholar
• Marimuthu, P., P. K. Balasubramanian, and K. Singaravelu. 2018. Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein. Journal of Biomolecular Structure & Dynamics 36 (10):2654–67.
   PubMed Web of Science ®Google Scholar
• Matsushita, M., K. Fujita, D. Motooka, K. Hatano, S. Fukae, N. Kawamura, E. Tomiyama, Y. Hayashi, E. Banno, T. Takao, et al. 2021. The gut microbiota associated with high‐Gleason prostate cancer. Cancer Science 112 (8):3125–35.
   PubMed Web of Science ®Google Scholar
• Menet, M. C., S. Baron, M. Taghi, R. Diestra, D. Dargère, O. Laprévote, V. Nivet‐Antoine, J. L. Beaudeux, T. Bédarida, and C. H. Cottart. 2017. Distribution of trans‐resveratrol and its metabolites after acute or sustained administration in mouse heart, brain, and liver. Molecular Nutrition & Food Research 61 (8):1600686. doi: 10.1002/mnfr.201600686.
   Web of Science ®Google Scholar
• Meng, X., P. Maliakal, H. Lu, M.-J. Lee, and C. S. Yang. 2004. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice. Journal of Agricultural and Food Chemistry 52 (4):935–42.
   PubMed Web of Science ®Google Scholar
• Miksits, M., A. Maier-Salamon, S. Aust, T. Thalhammer, G. Reznicek, O. Kunert, E. Haslinger, T. Szekeres, and W. Jaeger. 2005. Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 35 (12):1101–19. doi: 10.1080/00498250500354253.
   PubMed Web of Science ®Google Scholar
• Milton-Laskibar, I., L. J. Marcos-Zambrano, S. Gómez-Zorita, A. Fernández-Quintela, E. Carrillo de Santa Pau, J. A. Martínez, and M. P. Portillo. 2021. Gut microbiota induced by pterostilbene and resveratrol in high-fat-high-fructose fed rats: putative role in steatohepatitis onset. Nutrients 13 (5):1738. doi: 10.3390/nu13051738.
   PubMed Web of Science ®Google Scholar
• Montgomery, M, and A. Srinivasan. 2019. Epigenetic gene regulation by dietary compounds in cancer prevention. Advances in Nutrition (Bethesda, Md.) 10 (6):1012–28.
   PubMed Web of Science ®Google Scholar
• Ni, Y., Z. Lohinai, Y. Heshiki, B. Dome, J. Moldvay, E. Dulka, G. Galffy, J. Berta, G. J. Weiss, M. O. A. Sommer, et al. 2021. Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients. The ISME Journal 15 (11):3207–20.
   PubMed Web of Science ®Google Scholar
• Och, O. 2019. Enzymes involved in xenobiotic metabolism. In Evaluation of environmental contaminants and natural products: A human health perspective, eds. A. Sharma, M. Kumar, S. Kaur, and A. K. Nagpal, p. 165. Tsukuba Science City, Japan: National Institute of Advanced Industrial Science & Technology (AIST).
   Google Scholar
• Ortuño, J., M.-I. Covas, M. Farre, M. Pujadas, M. Fito, O. Khymenets, C. Andres-Lacueva, P. Roset, J. Joglar, R. M. Lamuela-Raventós, et al. 2010. Matrix effects on the bioavailability of resveratrol in humans. Food Chemistry 120 (4):1123–30. doi: 10.1016/j.foodchem.2009.11.032.
   Web of Science ®Google Scholar
• Pannu, N, and A. Bhatnagar. 2019. Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 109:2237–51. doi: 10.1016/j.biopha.2018.11.075.
   PubMed Web of Science ®Google Scholar
• Partula, V., M. Deschasaux, N. Druesne-Pecollo, P. Latino-Martel, E. Desmetz, E. Chazelas, E. Kesse-Guyot, C. Julia, L. K. Fezeu, P. Galan, The Milieu Intérieur Consortium, et al. 2020. Associations between consumption of dietary fibers and the risk of cardiovascular diseases, cancers, type 2 diabetes, and mortality in the prospective NutriNet-Sante cohort. The American Journal of Clinical Nutrition 112 (1):195–207. doi: 10.1093/ajcn/nqaa063.
   PubMed Web of Science ®Google Scholar
• Patel, K. R., C. Andreadi, R. G. Britton, E. Horner-Glister, A. Karmokar, S. Sale, V. A. Brown, D. E. Brenner, R. Singh, W. P. Steward, et al. 2013. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. Science Translational Medicine 5 (205):205ra133.
   PubMed Web of Science ®Google Scholar
• Peiffer, D. S. 2020. Modulation of the host microbiome by black raspberries or their components and the therapeutic implications in cancer. Food Frontiers 1 (3):296–304. doi: 10.1002/fft2.40.
   Google Scholar
• Polycarpou, E., L. B. Meira, S. Carrington, E. Tyrrell, H. Modjtahedi, and M. A. Carew. 2013a. Resveratrol 3-O-D-glucuronide and resveratrol 4 ‘-O-D-glucuronide inhibit colon cancer cell growth: evidence for a role of A3 adenosine receptors, cyclin D1 depletion, and G1 cell cycle arrest. Molecular Nutrition & Food Research 57 (10):1708–17. doi: 10.1002/mnfr.201200742.
   PubMed Web of Science ®Google Scholar
• Polycarpou, E., L. B. Meira, S. Carrington, E. Tyrrell, H. Modjtahedi, and M. A. Carew. 2013b. Resveratrol 3‐O‐d‐glucuronide and resveratrol 4′‐O‐d‐glucuronide inhibit colon cancer cell growth: evidence for a role of A 3 adenosine receptors, cyclin D 1 depletion, and G 1 cell cycle arrest. Molecular Nutrition & Food Research 57 (10):1708–17. doi: 10.1002/mnfr.201200742.
   PubMed Web of Science ®Google Scholar
• Ponziani, F. R., S. Bhoori, C. Castelli, L. Putignani, L. Rivoltini, F. Del Chierico, M. Sanguinetti, D. Morelli, F. Paroni Sterbini, V. Petito, et al. 2019. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 69 (1):107–20.
   PubMed Web of Science ®Google Scholar
• Qiao, Y., J. Sun, S. Xia, X. Tang, Y. Shi, and G. Le. 2014. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food & Function 5 (6):1241–9. doi: 10.1039/c3fo60630a.
   PubMed Web of Science ®Google Scholar
• Qiu, Z., J. Yu, Y. Dai, X. Chen, F. Huang, and N. Li. 2017. A simple LC–MS/MS method for the simultaneous quantification of resveratrol and its major phase II metabolites: assessment of their urinary and biliary excretions in rats. Journal of Chromatography B 1048:85–93. doi: 10.1016/j.jchromb.2017.02.011.
   PubMed Web of Science ®Google Scholar
• Ratajczak, K, and S. Borska. 2021. Cytotoxic and proapoptotic effects of resveratrol in in vitro studies on selected types of gastrointestinal cancers. Molecules 26 (14):4350. doi: 10.3390/molecules26144350.
   PubMed Web of Science ®Google Scholar
• Revel, A., H. Raanani, E. Younglai, J. Xu, I. Rogers, R. Han, J. F. Savouret, and R. F. Casper. 2003. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo [a] pyrene. Journal of Applied Toxicology 23 (4):255–61. doi: 10.1002/jat.916.
   PubMed Web of Science ®Google Scholar
• Ridlon, J. M., P. G. Wolf, and H. R. Gaskins. 2016. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 7 (3):201–15.
   PubMed Web of Science ®Google Scholar
• Román-Román, A., D. N. Martínez-Carrillo, J. Atrisco-Morales, J. C. Azúcar-Heziquio, A. S. Cuevas-Caballero, C. A. Castañón-Sánchez, R. Reyes-Ríos, R. Betancourt-Linares, S. Reyes-Navarrete, I. Cruz-del Carmen, et al. 2017. Helicobacter pylori vacA s1m1 genotype but not cagA or babA2 increase the risk of ulcer and gastric cancer in patients from Southern Mexico. Gut Pathogens 9 (1):1–12. doi: 10.1186/s13099-017-0167-z.
   PubMedGoogle Scholar
• Rotches-Ribalta, M., C. Andres-Lacueva, R. Estruch, E. Escribano, and M. Urpi-Sarda. 2012. Pharmacokinetics of resveratrol metabolic profile in healthy humans after moderate consumption of red wine and grape extract tablets. Pharmacological Research 66 (5):375–82.
   PubMed Web of Science ®Google Scholar
• Rotches-Ribalta, M., M. Urpi-Sarda, R. Llorach, M. Boto-Ordoñez, O. Jauregui, G. Chiva-Blanch, L. Perez-Garcia, W. Jaeger, M. Guillen, D. Corella, et al. 2012. Gut and microbial resveratrol metabolite profiling after moderate long-term consumption of red wine versus dealcoholized red wine in humans by an optimized ultra-high-pressure liquid chromatography tandem mass spectrometry method. Journal of Chromatography A 1265:105–13.
   PubMed Web of Science ®Google Scholar
• Sacks, D., B. Baxter, B. C. V. Campbell, J. S. Carpenter, C. Cognard, D. Dippel, M. Eesa, U. Fischer, K. Hausegger, et al. 2018. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. International Journal of Stroke: Official Journal of the International Stroke Society 13 (6):612–32.
   PubMed Web of Science ®Google Scholar
• Sale, S., R. D. Verschoyle, D. Boocock, D. J. L. Jones, N. Wilsher, K. C. Ruparelia, G. A. Potter, P. B. Farmer, W. P. Steward, and A. J. Gescher. 2004. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4 ‘-tetramethoxystilbene. British Journal of Cancer 90 (3):736–44. doi: 10.1038/sj.bjc.6601568.
   PubMed Web of Science ®Google Scholar
• Sapienza, C, and J. P. Issa. 2016. Diet, nutrition, and cancer epigenetics. Annual Review of Nutrition 36:665–81. doi: 10.1146/annurev-nutr-121415-112634.
   PubMed Web of Science ®Google Scholar
• Schroeter, A., I. A. M. Groh, G. Del Favero, M. Pignitter, K. Schueller, V. Somoza, and D. Marko. 2015. Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells. Molecular Nutrition & Food Research 59 (12):2448–59. doi: 10.1002/mnfr.201500352.
   PubMed Web of Science ®Google Scholar
• Sehrawat, N., M. Yadav, M. Singh, V. Kumar, V. R. Sharma, and A. K. Sharma. 2021. Probiotics in microbiome ecological balance providing a therapeutic window against cancer. Seminars in Cancer Biology 70:24–36. doi: 10.1016/j.semcancer.2020.06.009.
   PubMed Web of Science ®Google Scholar
• Sergides, C., M. Chirilă, L. Silvestro, D. Pitta, and A. Pittas. 2016. Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers. Experimental and Therapeutic Medicine 11 (1):164–70.
   PubMed Web of Science ®Google Scholar
• Sessa, M., M. L. Balestrieri, G. Ferrari, L. Servillo, D. Castaldo, N. D’Onofrio, F. Donsi, and R. Tsao. 2014. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chemistry 147:42–50.
   PubMed Web of Science ®Google Scholar
• Si, W., H. Liang, J. Bugno, Q. Xu, X. Ding, K. Yang, Y. Fu, R. R. Weichselbaum, X. Zhao, and L. Wang. 2022. Lactobacillus rhamnosus GG induces cGAS/STING-dependent type I interferon and improves response to immune checkpoint blockade. Gut 71 (3):521–33. doi: 10.1136/gutjnl-2020-323426.
   PubMed Web of Science ®Google Scholar
• Sieniawska, E., M. Maciejewska‐Turska, Ł. Świątek, and J. Xiao. 2020. Plant‐based food products for antimycobacterial therapy. eFood 1 (3):199–216. doi: 10.2991/efood.k.200418.001.
   Google Scholar
• Soleas, G. J., M. Angelini, L. Grass, E. P. Diamandis, and D. M. Goldberg. 2001. Absorption of trans-resveratrol in rats. Methods in Enzymology 335:145–54.
   PubMed Web of Science ®Google Scholar
• Song, H., J. I. Jung, H. J. Cho, S. Her, S.-H. Kwon, R. Yu, Y.-H. Kang, K. W. Lee, and J. H. Y. Park. 2015. Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration. The Journal of Nutritional Biochemistry 26 (11):1368–78.
   PubMed Web of Science ®Google Scholar
• Song, N. R., M. K. Hwang, Y.-S. Heo, K. W. Lee, and H. J. Lee. 2013. Piceatannol suppresses the metastatic potential of MCF10A human breast epithelial cells harboring mutated H-ras by inhibiting MMP-2 expression. International Journal of Molecular Medicine 32 (4):775–84.
   PubMed Web of Science ®Google Scholar
• Song, W., K. Tiruthani, Y. Wang, L. Shen, M. Hu, O. Dorosheva, K. Qiu, K. A. Kinghorn, R. Liu, and L. Huang. 2018. Trapping of lipopolysaccharide to promote immunotherapy against colorectal cancer and attenuate liver metastasis. Advanced Materials 30 (52):1805007. doi: 10.1002/adma.201805007.
   Web of Science ®Google Scholar
• Steed, A. L., G. P. Christophi, G. E. Kaiko, L. Sun, V. M. Goodwin, U. Jain, E. Esaulova, M. N. Artyomov, D. J. Morales, M. J. Holtzman, et al. 2017. The microbial metabolite desaminotyrosine protects from influenza through type I interferon. Science (New York, N.Y.) 357 (6350):498–502.
   PubMed Web of Science ®Google Scholar
• Su, M., C. Dong, J. Wan, and M. Zhou. 2019. Pharmacokinetics, tissue distribution and excretion study of trans-resveratrol-3-O-glucoside and its two metabolites in rats. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 58:152882.
   PubMed Web of Science ®Google Scholar
• Sun, B, and M. Karin. 2012. Obesity, inflammation, and liver cancer. Journal of Hepatology 56 (3):704–13. doi: 10.1016/j.jhep.2011.09.020.
   PubMed Web of Science ®Google Scholar
• Svilar, L., J.-C. Martin, C. Defoort, C. Paut, F. Tourniaire, and A. Brochot. 2019. Quantification of trans-resveratrol and its metabolites in human plasma using ultra-high performance liquid chromatography tandem quadrupole-orbitrap mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 1104:119–29.
   PubMed Web of Science ®Google Scholar
• Tian, Q., X. Fan, J. Ma, Y. Han, D. Li, S. Jiang, F. Zhang, H. Guang, X. Shan, R. Chen, et al. 2020. Resveratrol ameliorates lipopolysaccharide-induced anxiety-like behavior by attenuating YAP-mediated neuro-inflammation and promoting hippocampal autophagy in mice. Toxicology and Applied Pharmacology 408:115261.
   PubMed Web of Science ®Google Scholar
• Tremaroli, V, and F. Bäckhed. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489 (7415):242–9.
   PubMed Web of Science ®Google Scholar
• Tsang, S. W., Y.-F. Guan, J. Wang, Z.-X. Bian, and H.-J. Zhang. 2016. Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis. Scientific Reports 6:22859. doi: 10.1038/srep22859.
   PubMed Web of Science ®Google Scholar
• Ubachs, J., J. Ziemons, Z. Soons, R. Aarnoutse, D. P. Dijk, J. Penders, A. Helvoort, M. L. Smidt, R. F. Kruitwagen, L. Baade‐Corpelijn, et al. 2021. Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients. Journal of Cachexia, Sarcopenia and Muscle 12 (6):2007–21. doi: 10.1002/jcsm.12804.
   PubMed Web of Science ®Google Scholar
• Vitrac, X., A. Desmouliere, B. Brouillaud, S. Krisa, G. Deffieux, N. Barthe, J. Rosenbaum, and J.-M. Mérillon. 2003. Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sciences 72 (20):2219–33.
   PubMed Web of Science ®Google Scholar
• Walle, T., F. Hsieh, M. H. DeLegge, J. E. Oatis, and U. K. Walle. 2004. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 32 (12):1377–82. doi: 10.1124/dmd.104.000885.
   PubMed Web of Science ®Google Scholar
• Wang, H., Q. He, G. Wang, X. Xu, and H. Hao. 2018. FXR modulators for enterohepatic and metabolic diseases. Expert Opinion on Therapeutic Patents 28 (11):765–82. doi: 10.1080/13543776.2018.1527906.
   PubMed Web of Science ®Google Scholar
• Wang, H., H. Zhou, Y. Zou, Q. Liu, C. Guo, G. Gao, C. Shao, and Y. Gong. 2010. Resveratrol modulates angiogenesis through the GSK3β/β-catenin/TCF-dependent pathway in human endothelial cells. Biochemical Pharmacology 80 (9):1386–95.
   PubMed Web of Science ®Google Scholar
• Wang, P., J. Gao, W. Ke, J. Wang, D. Li, R. Liu, Y. Jia, X. Wang, X. Chen, F. Chen, et al. 2020. Resveratrol reduces obesity in high-fat diet-fed mice via modulating the composition and metabolic function of the gut microbiota. Free Radical Biology & Medicine 156:83–98.
   PubMed Web of Science ®Google Scholar
• Wang, P., D. Li, W. Ke, D. Liang, X. Hu, and F. Chen. 2020. Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice. International Journal of Obesity (2005) 44 (1):213–25.
   PubMed Web of Science ®Google Scholar
• Wang, P, and S. Sang. 2018. Metabolism and pharmacokinetics of resveratrol and pterostilbene. BioFactors (Oxford, England) 44 (1):16–25. doi: 10.1002/biof.1410.
   PubMed Web of Science ®Google Scholar
• Wang, P., J. Wang, D. Li, W. Ke, F. Chen, and X. Hu. 2020. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. The Journal of Nutritional Biochemistry 81:108363.
   PubMed Web of Science ®Google Scholar
• Wang, S., Z. Wang, S. Yang, T. Yin, Y. Zhang, Y. Qin, R. N. Weinreb, and X. Sun. 2017. Tissue distribution of trans-resveratrol and its metabolites after oral administration in human eyes. Journal of Ophthalmology 2017:1–12. doi: 10.1155/2017/4052094.
   Web of Science ®Google Scholar
• Ward, N. C., K. D. Croft, I. B. Puddey, and J. M. Hodgson. 2004. Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. Journal of Agricultural and Food Chemistry 52 (17):5545–9. doi: 10.1021/jf049404r.
   PubMed Web of Science ®Google Scholar
• Warren, R. L., D. J. Freeman, S. Pleasance, P. Watson, R. A. Moore, K. Cochrane, E. Allen-Vercoe, and R. A. Holt. 2013. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 1:1–12.
   PubMed Web of Science ®Google Scholar
• Wenzel, E., T. Soldo, H. Erbersdobler, and V. Somoza. 2005. Bioactivity and metabolism of trans‐resveratrol orally administered to Wistar rats. Molecular Nutrition & Food Research 49 (5):482–94. doi: 10.1002/mnfr.200500003.
   PubMed Web of Science ®Google Scholar
• WHO 2021. Latest global cancer data: cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020.
   Google Scholar
• Wirbel, J., P. T. Pyl, E. Kartal, K. Zych, A. Kashani, A. Milanese, J. S. Fleck, A. Y. Voigt, A. Palleja, R. Ponnudurai, et al. 2019. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nature Medicine 25 (4):679–89.
   PubMed Web of Science ®Google Scholar
• Xie, Y.-H., Q.-Y. Gao, G.-X. Cai, X.-M. Sun, T.-H. Zou, H.-M. Chen, S.-Y. Yu, Y.-W. Qiu, W.-Q. Gu, X.-Y. Chen, et al. 2017. Fecal Clostridium symbiosum for noninvasive detection of early and advanced colorectal cancer: test and validation studies. EBioMedicine 25:32–40. doi: 10.1016/j.ebiom.2017.10.005.
   PubMed Web of Science ®Google Scholar
• Yachida, S., S. Mizutani, H. Shiroma, S. Shiba, T. Nakajima, T. Sakamoto, H. Watanabe, K. Masuda, Y. Nishimoto, M. Kubo, et al. 2019. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nature Medicine 25 (6):968–76.
   PubMed Web of Science ®Google Scholar
• Yazici, C., P. G. Wolf, H. Kim, T.-W L. Cross, K. Vermillion, T. Carroll, G. J. Augustus, E. Mutlu, L. Tussing-Humphreys, C. Braunschweig, et al. 2017. Race-dependent association of sulfidogenic bacteria with colorectal cancer. Gut 66 (11):1983–94. doi: 10.1136/gutjnl-2016-313321.
   PubMed Web of Science ®Google Scholar
• Yen, G. C., C. M. Tsai, C. C. Lu, and C. J. Weng. 2018. Recent progress in natural dietary non-phenolic bioactives on cancers metastasis. Journal of Food and Drug Analysis 26 (3):940–64.
   PubMed Web of Science ®Google Scholar
• Yu, C., Z. Su, Y. Li, Y. Li, K. Liu, F. Chu, T. Liu, R. Chen, and X. Ding. 2020. Dysbiosis of gut microbiota is associated with gastric carcinogenesis in rats. Biomedicine & Pharmacotherapy 126:110036. doi: 10.1016/j.biopha.2020.110036.
   PubMed Web of Science ®Google Scholar
• Yuan, L., Y. Zhang, J. Xia, B. Liu, Q. Zhang, J. Liu, L. Luo, Z. Peng, Z. Song, and R. Zhu. 2015. Resveratrol induces cell cycle arrest via a p53-independent pathway in A549 cells. Molecular Medicine Reports 11 (4):2459–64. doi: 10.3892/mmr.2014.3100.
   PubMed Web of Science ®Google Scholar
• Zackular, J. P., N. T. Baxter, K. D. Iverson, W. D. Sadler, J. F. Petrosino, G. Y. Chen, and P. D. Schloss. 2013. The gut microbiome modulates colon tumorigenesis. mBio 4 (6):e00692-00613–e00613.
   Web of Science ®Google Scholar
• Zamora-Ros, R., D. Achaintre, J. A. Rothwell, S. Rinaldi, N. Assi, P. Ferrari, M. Leitzmann, M.-C. Boutron-Ruault, G. Fagherazzi, A. Auffret, et al. 2016. Urinary excretions of 34 dietary polyphenols and their associations with lifestyle factors in the EPIC cohort study. Scientific Reports 6 (1): 1–9. doi: 10.1038/srep26905.
   PubMedGoogle Scholar
• Zeller, G., J. Tap, A. Y. Voigt, S. Sunagawa, J. R. Kultima, P. I. Costea, A. Amiot, J. Böhm, F. Brunetti, N. Habermann, et al. 2014. Potential of fecal microbiota for early‐stage detection of colorectal cancer. Molecular Systems Biology 10:766.
   PubMed Web of Science ®Google Scholar
• Zhang, B., Y. Xu, H. Lv, W. Pang, J. Wang, H. Ma, and S. Wang. 2021. Intestinal pharmacokinetics of resveratrol and regulatory effects of resveratrol metabolites on gut barrier and gut microbiota. Food Chemistry 357:129532.
   PubMed Web of Science ®Google Scholar
• Zhang, H.-L., L.-X. Yu, W. Yang, L. Tang, Y. Lin, H. Wu, B. Zhai, Y.-X. Tan, L. Shan, Q. Liu, et al. 2012. Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats. Journal of Hepatology 57 (4):803–12.
   PubMed Web of Science ®Google Scholar
• Zhao, H., Z. Jiang, X. Chang, H. Xue, W. Yahefu, and X. Zhang. 2018. 4-Hydroxyphenylacetic acid prevents acute APAP-induced liver injury by increasing phase II and antioxidant enzymes in mice. Frontiers in Pharmacology 9:1–10. doi: 10.3389/fphar.2018.00653.
   PubMed Web of Science ®Google Scholar
• Zhang, H., G. Caprioli, H. Hussain, N. P. K. Le, M. A. Farag, and J. Xiao. 2021. A multifaceted review on dihydromyricetin resources, extraction, bioavailability, biotransformation, bioactivities, and food applications with future perspectives to maximize its value. eFood 2 (4):164–84. doi: 10.53365/efood.k/143518.
   Google Scholar
• Zhang, L., Y.-N. Wu, T. Chen, C.-H. Ren, X. Li, and G.-X. Liu. 2019. Relationship between intestinal microbial dysbiosis and primary liver cancer. Hepatobiliary & Pancreatic Diseases International: HBPD INT 18 (2):149–57.
   PubMed Web of Science ®Google Scholar
• Zhang, X., O. O. Coker, E. S. Chu, K. Fu, H. C. H. Lau, Y.-X. Wang, A. W. H. Chan, H. Wei, X. Yang, J. J. Y. Sung, et al. 2021. Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 70 (4):761–74.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., J. Shen, X. Shi, Y. Du, Y. Niu, G. Jin, Z. Wang, and J. Lyu. 2021. Gut microbiome analysis as a predictive marker for the gastric cancer patients. Applied Microbiology and Biotechnology 105 (2):803–14.
   PubMed Web of Science ®Google Scholar
• Zheng, Y., Z. Fang, Y. Xue, J. Zhang, J. Zhu, R. Gao, S. Yao, Y. Ye, S. Wang, C. Lin, et al. 2020. Specific gut microbiome signature predicts the early-stage lung cancer. Gut Microbes 11 (4):1030–42.
   PubMed Web of Science ®Google Scholar
• Zhou, X., Y. Zhao, J. Wang, X. Wang, C. Chen, D. Yin, F. Zhao, J. Yin, M. Guo, L. Zhang, et al. 2018. Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation. Biochemical Pharmacology 155:252–63.
   PubMed Web of Science ®Google Scholar
• Zhu, G., Q. Huang, Y. Huang, W. Zheng, J. Hua, S. Yang, J. Zhuang, J. Wang, and J. Ye. 2016. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4-NF-κB/JNK pathways in colorectal cancer. Oncotarget 7 (45):73711–24. doi: 10.18632/oncotarget.12449.
   PubMedGoogle Scholar
• Zhu, J., M. Liao, Z. Yao, W. Liang, Q. Li, J. Liu, H. Yang, Y. Ji, W. Wei, A. Tan, et al. 2018. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome 6 (1):1–13. doi: 10.1186/s40168-018-0515-3.
   PubMedGoogle Scholar